Bethlehem biotech company receives funding for cancer research

BETHLEHEM – A biotech company based at Ben Franklin Technology Partners of Northeastern Pennsylvania’s TechVentures has received an initial investment of $ 1.3 million to pursue its specialty in cancer diagnostics testing.

Ben Franklin said in a news release that Cernostics Inc. is receiving the…

This story original published here: Business – The Morning Call